Effects of Remote Ischaemic Preconditioning on the Internal Thoracic Artery Nitric Oxide Synthase Isoforms in Patients Undergoing Coronary Artery Bypass Grafting.
Aleksandra JankovicTamara ZakicMiroslav MilicicDragana Unic-StojanovicAndjelika KalezicAleksandra KoraćMiomir JovicBato KoracPublished in: Antioxidants (Basel, Switzerland) (2021)
Remote ischaemic preconditioning (RIPC) is a medical procedure that consists of repeated brief periods of transient ischaemia and reperfusion of distant organs (limbs) with the ability to provide internal organ protection from ischaemia. Even though RIPC has been successfully applied in patients with myocardial infarction during coronary revascularization (surgery/percutaneous angioplasty), the underlying molecular mechanisms are yet to be clarified. Thus, our study aimed to determine the role of nitric oxide synthase (NOS) isoforms in RIPC-induced protection (3 × 5 min of forearm ischaemia with 5 min of reperfusion) of arterial graft in patients undergoing urgent coronary artery bypass grafting (CABG). We examined RIPC effects on specific expression and immunolocalization of three NOS isoforms - endothelial (eNOS), inducible (iNOS) and neuronal (nNOS) in patients' internal thoracic artery (ITA) used as a graft. We found that the application of RIPC protocol leads to an increased protein expression of eNOS, which was further confirmed with strong eNOS immunopositivity, especially in the endothelium and smooth muscle cells of ITA. The same analysis of two other NOS isoforms, iNOS and nNOS, showed no significant differences between patients undergoing CABG with or without RIPC. Our results demonstrate RIPC-induced upregulation of eNOS in human ITA, pointing to its significance in achieving protective phenotype on a systemic level with important implications for graft patency.
Keyphrases
- nitric oxide synthase
- coronary artery bypass grafting
- nitric oxide
- patients undergoing
- cerebral ischemia
- coronary artery disease
- percutaneous coronary intervention
- endothelial cells
- minimally invasive
- acute myocardial infarction
- high glucose
- subarachnoid hemorrhage
- poor prognosis
- end stage renal disease
- coronary artery bypass
- blood brain barrier
- spinal cord
- newly diagnosed
- randomized controlled trial
- healthcare
- chronic kidney disease
- brain injury
- ischemia reperfusion injury
- lymph node
- acute coronary syndrome
- ejection fraction
- coronary artery
- left ventricular
- oxidative stress
- prognostic factors
- ultrasound guided
- long non coding rna
- transcatheter aortic valve replacement
- induced pluripotent stem cells
- patient reported outcomes
- stress induced